Do patients with submassive pulmonary embolism benefit from thrombolytic therapy?
Cleve Clin J Med. 2016 Dec;83(12):923-932
Authors: Ataya A, Cope J, Shahmohammadi A, Alnuaimat H
Abstract
Despite growing interest in thrombolytic agents to treat submassive pulmonary embolism, their role in this scenario remains controversial. Needed is a way to identify patients with this condition who are at risk of clinical deterioration and who would benefit from thrombolytic therapy. Here, we review the use of thrombolytic agents in submassive pulmonary embolism to help distinguish the risk and benefits of this therapy.
PMID: 27938515 [PubMed - in process]